• Platform

  • Aktiesparekonto

  • Priser

  • Blog

  • MCP

  • Support

  • Populære aktier

InstagramLinkedInTikTokFacebook
Opret konto
Få appenScan koden
QR-kode til download af Endavu-appen
Log ind
TEVA1N
Teva Pharmaceutical Industries
Mexican Stock Exchange

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TEVA PHARMACEUTICAL INDUSTRIES MED ENDAVU: Køb Teva Pharmaceutical Industries ($TEVA1N) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Teva Pharmaceutical Industries, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Teva Pharmaceutical Industries Limited is a global pharmaceutical company focused on developing, manufacturing, marketing, and distributing generic medicines, specialty medicines, and biopharmaceutical products. Teva Pharmaceutical Industries Limited serves patients and healthcare providers across North America, Europe, Israel, and other international markets through a broad portfolio that includes tablets, capsules, injectables, inhalants, liquids, creams, ointments, and combination products. The company also supplies active pharmaceutical ingredients, provides certain contract manufacturing services, and supports product out-licensing activities. Its business is centered on widely used therapies across areas such as neurology, immunology, and other treatment categories, making it an important supplier in the global healthcare and medicines market.

Information

TickerTEVA1N
Land
Israel
Antal medarbejdere31.173
Hjemmesidetevapharm.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk